The global medical devices market size is expected to hit around USD 850 billion by 2030 and progressing a CAGR of 5.5% over the forecast period 2022 to 2030.
The on medical
devices Market, which provides a business strategy, research & development
activities, concise outline of the market valuation, valuable insights
pertaining to market share, size, supply chain analysis, competitive landscape
and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1129
Report Scope of the Medical Devices Market
Report Highlights | Details |
Market Size | USD 850 Billion by 2030 |
Growth Rate | CAGR of 5.5% From 2022 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2022 to 2027 |
Segments Covered | Product, Therapeutic Application, End User, Region |
Regional Scope | Asia Pacific, North America, Europe, Latin America, Middle East and Africa |
A recent
report provides crucial insights along with application based and forecast
information in the Global Medical devices Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Medical devices market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Medical devices market are
included as given below:
Medical devices Market Key Players
- DePuy Synthes
- Medtronics Plc
- Fesenius Medical Care
- GE Healthcare
- Philips Healthcare
- Ethicon LLC
- Siemens Healthineers
- Stryker
- Cardinal Health
- Baxter International Inc.
- BD
Market Segments
- Monitoring Devices
- Cardiac Monitoring Devices
- Neuromonitoring Devices
- Respiratory Monitoring Device
- Multi-Parameter Monitoring Devices
- Hemodynamic Monitoring Devices
- Fetal and Neonatal Monitoring Devices
- Temperature Monitoring Devices
- Weight Monitoring Devices
- Diagnostic Devices
- Surgical ENT Devices.
- Endoscopes
- Imaging Devices
- Diagnostic Molecular Devices
- Drug Delivery Devices
- Surgical Devices
- Bio Implants and Stimulation Devices
- Treatment Equipment
- Infusion Pumps
- Medical lasers and LASIK surgical machines
- Others
By Therapeutic Application
- Gastrointestinal surgery
- General Surgery
- Diagnostic Imaging
- Respiratory
- Orthopedics
- Cardiovascular
- Dental
- Neurology
- Ophthalmology
- Ear-Nose-Throat (ENT)
- Nephrology and Urology
- Others
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Research laboratory
- Pharmaceutical companies
By Regional Outlook
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Rest of the World
Report Objectives
- To define, describe, and forecast the global medical
devices market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the medical
devices market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Devices Market
5.1. COVID-19 Landscape: Medical Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Devices Market, By Product
8.1. Medical Devices Market, by Product Type, 2022-2030
8.1.1. Monitoring Devices
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Cardiac Monitoring Devices
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Respiratory Monitoring Device
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Multi-Parameter Monitoring Devices
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Hemodynamic Monitoring Devices
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Fetal and Neonatal Monitoring Devices
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Temperature Monitoring Devices
8.1.7.1. Market Revenue and Forecast (2019-2030)
8.1.8. Weight Monitoring Devices
8.1.8.1. Market Revenue and Forecast (2019-2030)
8.1.9. Diagnostic Devices
8.1.9.1. Market Revenue and Forecast (2019-2030)
8.1.10. Surgical ENT Devices.
8.1.10.1. Market Revenue and Forecast (2019-2030)
8.1.11. Endoscopes
8.1.11.1. Market Revenue and Forecast (2019-2030)
8.1.12. Imaging Devices
8.1.12.1. Market Revenue and Forecast (2019-2030)
8.1.13. Diagnostic Molecular Devices
8.1.13.1. Market Revenue and Forecast (2019-2030)
8.1.14. Drug Delivery Devices
8.1.14.1. Market Revenue and Forecast (2019-2030)
8.1.15. Surgical Devices
8.1.15.1. Market Revenue and Forecast (2019-2030)
8.1.16. Bio Implants and Stimulation Devices
8.1.16.1. Market Revenue and Forecast (2019-2030)
8.1.17. Treatment Equipment
8.1.17.1. Market Revenue and Forecast (2019-2030)
8.1.18. Infusion Pumps
8.1.18.1. Market Revenue and Forecast (2019-2030)
8.1.19. Medical lasers and LASIK surgical machines
8.1.19.1. Market Revenue and Forecast (2019-2030)
8.1.20. Others
8.1.20.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Medical Devices Market, By Therapeutic Application
9.1. Medical Devices Market, by Therapeutic Application, 2022-2030
9.1.1. Gastrointestinal surgery
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. General Surgery
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Diagnostic Imaging
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Respiratory
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Orthopedics
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Cardiovascular
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Dental
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Neurology
9.1.8.1. Market Revenue and Forecast (2019-2030)
9.1.9. Ophthalmology
9.1.9.1. Market Revenue and Forecast (2019-2030)
9.1.10. Ear-Nose-Throat (ENT)
9.1.10.1. Market Revenue and Forecast (2019-2030)
9.1.11. Nephrology and Urology
9.1.11.1. Market Revenue and Forecast (2019-2030)
9.1.12. Others
9.1.12.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Medical Devices Market, By End User
10.1. Medical Devices Market, by End User, 2022-2030
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Diagnostic Centers
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Research laboratory
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pharmaceutical Companies
10.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Medical Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Medtronics Plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Johnson & Johnson
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Fesenius Medical Care
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. DePuy Synthes
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Abbott Laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Philips Healthcare
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ethicon LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Siemens Healthineers AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Stryker
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Cardinal Health
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Baxter International Inc.
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. BD
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments